Cover Image

Urticarial vasculitis in a girl with a positive SARS-CoV-2 IgG result

Saved in:

Bibliographic Details
Main Author:	Piotr Brzezinski (Author)
Format:	Book
Published:	Our Dermatology Online, 2021-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Urticarial Vasculitis in a Teenage Girl
by: Aaron McGuffin MD, et al.
Published: (2013)

Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
by: Lysandro Pinto Borges, et al.
Published: (2020)

SARS-CoV2 IgG antibody: Seroprevalence among health care workers
by: Om Prakash, et al.
Published: (2021)

Serological survey for IgG antibodies against SARS-CoV-2 from newborns and their mothers
by: Gabriela Soutto Mayor Assumpção Pinheiro, et al.
Published: (2022)

Development of SARS-CoV-2 specific IgG and IgA antibodies in serum and milk with different SARS-COV-2 vaccines in lactating women
by: Carolina Lechosa-Muñiz, et al.
Published: (2023)

Clinical Value of SARS-CoV2 IgM and IgG Antibodies in Diagnosis of COVID-19 in Suspected Cases
by: Feng Y
Published: (2020)

Detection of SARS-CoV-2 IgG antibodies and inflammatory cytokines in saliva-a pilot study
by: S. Wadhwa, et al.
Published: (2023)

mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
by: Charlie Fricke, et al.
Published: (2024)

Cord Blood SARS-CoV-2 IgG Antibodies and Their Association With Maternal Immunity and Neonatal Outcomes
by: Addy Cecilia Helguera-Repetto, et al.
Published: (2022)

SARS-CoV-2 induced IgA vasculitis confirmed with SARS-CoV-2 tissue testing
by: Ahmed N. Ansari, MD, et al.
Published: (2024)

Clinical and pathological differences between skin‐limited IgM/IgG vasculitis and skin‐limited IgA vasculitis
by: Miho Kawamura, et al.
Published: (2021)

Urticarial Vasculitis of the Legs
by: I-Ting Lee, et al.
Published: (2019)

Development of IgA vasculitis after SARS‐CoV‐2 vaccination
by: Yasuaki Ogura, et al.
Published: (2022)

SARS‑CoV‑2 IgG antibody status in unvaccinated and 2‑dose vaccinated Indonesians by Astra Zeneca
by: Laura Yamani, et al.
Published: (2023)

Evaluating the seroprevalence of SARS-CoV-2 IgG in five different districts of Bangladesh. A seroepidemiological study
by: Abdullah Al Saba, et al.
Published: (2023)

The serological IgG and neutralizing antibody of SARS-CoV-2 omicron variant reinfection in Jiangsu Province, China
by: Jinjin Chu, et al.
Published: (2024)

Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020.
by: Claude Flamand, et al.
Published: (2021)

Normocomplementaemic Urticarial Vasculitis in a 19-Month-Old Girl
by: Peter Williams
Published: (2016)

Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Healthcare Personnel in El Salvador Prior to Vaccination Campaigns
by: José Elías Aguilar Ramírez, et al.
Published: (2024)

Verificación del desempeño de la prueba rápida "AMP Rapid Test SARS-CoV-2 IgG/IgM- Cassettes"
by: Diana María Gil-Villa
Published: (2021)

Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India
by: Kouser Sideeq Lone, et al.
Published: (2022)

Validation of rapid antibody (IgG-IgM) test kit for SARS COV-2 infection in Qatar
by: Jesha Mundodan, et al.
Published: (2021)

Quantitative estimation of anti-spike SARS-CoV-2 IgG antibody response after covishield vaccination in healthcare workers
by: Megha Goyal, et al.
Published: (2022)

High prevalence of anti-SARS-CoV-2 IgG antibody in the Xikrin of Bacajá (Kayapó) indigenous population in the brazilian Amazon
by: Eliene Putira Sacuema Rodrigues, et al.
Published: (2021)

Seric IgG anti-SARS-CoV-2 pre- and post- Covid-19 pandemic from Mexican asymptomatic subjects
by: Lucinda Aguirre-Cruz, et al.
Published: (2022)

Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report
by: Yusuf Can Edek, et al.
Published: (2024)

CHRONIC URTICARIAL VASCULITIS AND IMMUNOGLOBULIN-G MONOCLONAL GAMMOPATHY: VARIANT SCHNITZLER SYNDROME
by: Shilpa Bhartia, et al.
Published: (2017)

Normocomplementemic urticarial vasculitis: An unusual presentation
by: Robin George Manappallil, et al.
Published: (2020)

Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG
by: Jamiruddin MR, et al.
Published: (2021)

Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina
by: Luz María Rodeles, et al.
Published: (2021)

The evaluation of IgG4 and IgG expression in cutaneous Rosai-Dorfman disease
by: Puyu Zou, et al.
Published: (2023)

The Levels of Anti-SARS-CoV-2 Spike Protein IgG Antibodies Before and After the Third Dose of Vaccination Against COVID-19
by: Łysek-Gładysińska M, et al.
Published: (2023)

Report of Two Cases of Pediatric IgG4-Related Lymphadenopathy (IgG4-LAD): IgG4-Related Disease (IgG4-RD) or a Distinct Clinical Pathological Entity?
by: Mariaclaudia Meli, et al.
Published: (2022)

A Young Man With Gravitational Urticarial Vasculitis
by: Ali Sadeghinia, et al.
Published: (2020)

A case of urticarial vasculitis associated with atezolizumab
by: Jade N. Young, BS, et al.
Published: (2024)

Comparison of diagnostic performance of RT-qPCR, RT-LAMP and IgM/IgG rapid tests for detection of SARS-CoV-2 among healthcare workers in Brazil
by: Wilma Patrícia de Oliveira Santos Bernardes, et al.
Published: (2023)

Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence population
by: Hackner, Klaus, et al.
Published: (2020)

Monogenic Inborn Errors of Immunity with impaired IgG response to polysaccharide antigens but normal IgG levels and normal IgG response to protein antigens
by: Maria Fasshauer, et al.
Published: (2024)

Plasma antibody levels (IgG1، IgG2) in periodontitis and control groups
by: Mosavi M., et al.
Published: (2009)

An ACE2-IgG4 Fc Fusion Protein Demonstrates Strong Binding to All Tested SARS-CoV-2 Variants and Reduced Lung Inflammation in Animal Models of SARS-CoV-2 and Influenza
by: Emmanuel Merigeon, et al.
Published: (2022)